BackBioNexus Gene Lab Overview

BioNexus Gene Lab Other Current Assets

Track BioNexus Gene Lab's other current assets ($2.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$2.93M

Peer average / median

Loading

BioNexus Gene Lab Other Current Assets History

Loading

BioNexus Gene Lab vs. peers: Other Current Assets Comparison

Loading

BioNexus Gene Lab Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioNexus Gene Lab (BGLC) FAQ

As of the most recent data (June 2026), BGLC shows a other current assets of $2.9M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BGLC's other current assets is now $2.9M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether BioNexus Gene Lab is outperforming or lagging.

Tracking BGLC's other current assets over time shows whether BioNexus Gene Lab is scaling, shrinking, or reshaping that part of the business. The current reading is $2.9M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has BioNexus Gene Lab's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $2.9M) with ownership activity and broader fundamentals.